Navidea Biopharmaceuticals To Participate In The BTIG Emerging Technologies In Healthcare Diagnostics Investor Conference September 30th
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will participate in the BTIG Emerging Technologies in Healthcare Diagnostics investor conference taking place September 29th and 30th in New York.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.